Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models-Reference-Cited by-同舟云学术

Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models

Published:2022-07 Issue: Volume:151 Page:113163
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Panebianco Concetta,Villani Annacandida,Pisati Federica,Orsenigo Fabrizio,Ulaszewska Marynka,Latiano Tiziana Pia,Potenza Adele,Andolfo Annapaola,Terracciano Fulvia,Tripodo Claudio,Perri Francesco,Pazienza Valerio

Funder

Associazione Italiana per la Ricerca sul Cancro

Ministero della Salute

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference59 articles.

1. Epidemiology of pancreatic cancer: global trends, etiology and risk factors;Rawla;World J. Oncol.,2019

2. Analysis of mortality rates for pancreatic cancer across the world;Hariharan;HPB,2008

3. Desmoplasia in pancreatic cancer. Can we fight it?;Merika;Gastroenterol. Res. Pract.,2012

4. Pancreatic cancer chemoresistance to gemcitabine;Amrutkar;Cancers,2017

5. Anticancer effects of the microbiome and its products;Zitvogel;Nat. Rev. Microbiol.,2017

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain;Gut Microbes;2024-09-04

2. SUMO3 inhibition by butyric acid suppresses cell viability and glycolysis and promotes gemcitabine antitumor activity in pancreatic cancer;Biology Direct;2024-08-26

3. Exploring the resilience and stability of a defined human gut microbiota consortium: An isothermal microcalorimetric study;MicrobiologyOpen;2024-08

4. Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria;Advanced Drug Delivery Reviews;2024-08

5. Double-blind randomized placebo-controlled supplementation of a standardized Terminalia chebula fruit extract alters the gut microbiome, phageome, and increases short chain fatty acids in High-BMI, borderline diabetic females;Journal of Functional Foods;2024-08